Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920694 · ClinicalTrials.gov registry record · NA
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
A NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05920694: Active NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, sponsored by University of California, San Francisco.
NCT05920694 is a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920694, a NA study of Obstructive Sleep Apnea and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the researchers are trying to learn more about the relationship between Polycystic Ovary Syndrome and Obstructive Sleep Apnea (OSA). Obstructive Sleep Apnea is a sleep-related breathing disorder that involves a decrease or complete stop in airflow. The purpose of this study is to find out why some people with obstructive sleep apnea have higher levels of insulin resistance, and the investigators will study the role of hypoxia (low levels of oxygen in the blood at night) in insulin resistance and see if insulin resistance improves during your treatment with CPAP.
Primary Outcome
The percent of newly synthesized fatty acids (DNL, %) will be measured using a stable isotope (deuterated water) and mass spectrometry.
Conditions Studied
Interventions
- DEVICE Continuous Positive Airway Pressure Device (CPAP)
- OTHER Delayed Continuous Positive Airway Pressure Device (CPAP)
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-12-22 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What the registry record for NCT05920694 still lists
NCT05920694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Continuous Positive Airway Pressure Device (CPAP) is the first listed.
NCT05920694 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05920694 about?
NCT05920694 is a clinical study titled "Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial". In this study, the researchers are trying to learn more about the relationship between Polycystic Ovary Syndrome and Obstructive Sleep Apnea (OSA). Obstructive Sleep Apnea is a sleep-related breathing disorder that involves a decrease or complete stop in airflow. The purpose of this study is to find...
What is the current status of trial NCT05920694?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-12-22. Estimated completion is 2026-07-30.
What conditions does trial NCT05920694 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT05920694?
The interventions under investigation include: Continuous Positive Airway Pressure Device (CPAP) (DEVICE), Delayed Continuous Positive Airway Pressure Device (CPAP) (OTHER).
Who is sponsoring clinical trial NCT05920694?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05920694 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05920694's enrollment target sits among peer trials
20 140th of 155 higher than 13 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI